Results 31 to 40 of about 36,705,319 (305)

The use and perception of electronic cigarettes and snus among the U.S. population. [PDF]

open access: yesPLoS ONE, 2013
E-cigarettes have generated controversy in the tobacco control field similar to that of Swedish snus, which came to the U.S. market six years earlier. Some argue that e-cigarettes have great potential to help smokers quit regular cigarettes while others ...
Shu-Hong Zhu   +5 more
doaj   +1 more source

“Knowledge, recommendation, and beliefs of e-cigarettes among physicians involved in tobacco cessation: A qualitative study”

open access: yesPreventive Medicine Reports, 2017
Physicians are rated the most trustworthy source of information for smokers and thus play an increasing role in disseminating information on e-cigarettes to patients.
Binu Singh   +5 more
doaj   +1 more source

Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA

open access: yesHarm Reduction Journal, 2018
Background Understanding the role that flavors play in the population’s use of e-cigarettes and the impact that flavored e-cigarette products have on the population’s use of more harmful tobacco products, like conventional cigarettes, has been identified
Christopher Russell   +3 more
doaj   +1 more source

Perceived ease of flavored e-cigarette use and e-cigarette use progression among youth never tobacco users.

open access: yesPLoS ONE, 2019
BACKGROUND:There is an increased need to understand how e-cigarette flavors may contribute to e-cigarette uptake and use among youth. We examined the relationship between perceived ease of flavored e-cigarette use and e-cigarette use susceptibility and ...
Julia Cen Chen-Sankey   +2 more
doaj   +1 more source

Public health consequences of e-cigarettes.

open access: yes, 2018
Millions of Americans use e-cigarettes. Despite their popularity, little is known about their health effects. Some suggest that e-cigarettes likely confer lower risk compared to combustible tobacco cigarettes, because they do not expose users to ...

core   +1 more source

E-cigarettes_Supplemental_File_2 – Supplemental material for A thematic analysis of smokers’ and non-smokers’ accounts of E-cigarettes

open access: yes, 2020
Supplemental material, E-cigarettes_Supplemental_File_2 for A thematic analysis of smokers’ and non-smokers’ accounts of E-cigarettes by Georgia Louise Wilson, Sarah Grogan, Susan Powell, Ivan Gee, Lorna Porcellato and Joseph Keenan in Journal of Health ...
Sarah Grogan (6206771)   +5 more
core   +1 more source

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer

open access: yesFEBS Open Bio, EarlyView.
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley   +1 more source

Electronic Cigarette Use and the Risk of Cardiovascular Diseases

open access: yesFrontiers in Cardiovascular Medicine, 2022
Electronic cigarettes or e-cigarettes are the most frequently used tobacco product among adolescents. Despite the widespread use of e-cigarettes and the known detrimental cardiac consequences of nicotine, the effects of e-cigarettes on the cardiovascular
Jorge Espinoza-Derout   +16 more
doaj   +1 more source

E-cigarettes_Supplemental_File_1 – Supplemental material for A thematic analysis of smokers’ and non-smokers’ accounts of E-cigarettes

open access: yes, 2020
Supplemental material, E-cigarettes_Supplemental_File_1 for A thematic analysis of smokers’ and non-smokers’ accounts of E-cigarettes by Georgia Louise Wilson, Sarah Grogan, Susan Powell, Ivan Gee, Lorna Porcellato and Joseph Keenan in Journal of Health ...
Sarah Grogan (6206771)   +5 more
core   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy